Kokki E - Search Results

1

Antiangiogenic AAV2 gene therapy with a truncated form of soluble VEGFR-2 reduces the growth of choroidal neovascularization in mice after intravitreal injection.

Puranen J, Koponen S, Nieminen T, Kanerva I, Kokki E, Toivanen P, Urtti A, Ylä-Herttuala S, Ruponen M. Puranen J, et al. Among authors: kokki e. Exp Eye Res. 2022 Nov;224:109237. doi: 10.1016/j.exer.2022.109237. Epub 2022 Sep 9. Exp Eye Res. 2022. PMID: 36096189 Free article.

2

Viral-Vector-Delivered Anti-Angiogenic Therapies to the Eye.

Koponen S, Kokki E, Kinnunen K, Ylä-Herttuala S. Koponen S, et al. Among authors: kokki e. Pharmaceutics. 2021 Feb 5;13(2):219. doi: 10.3390/pharmaceutics13020219. Pharmaceutics. 2021. PMID: 33562561 Free PMC article. Review.

3

Human Vascular Endothelial Growth Factor A₁₆₅ Expression Induces the Mouse Model of Neovascular Age-Related Macular Degeneration.

Kokki E, Karttunen T, Olsson V, Kinnunen K, Ylä-Herttuala S. Kokki E, et al. Genes (Basel). 2018 Aug 31;9(9):438. doi: 10.3390/genes9090438. Genes (Basel). 2018. PMID: 30200369 Free PMC article.

4

Preclinical safety, toxicology, and biodistribution study of adenoviral gene therapy with sVEGFR-2 and sVEGFR-3 combined with chemotherapy for ovarian cancer.

Tuppurainen L, Sallinen H, Kokki E, Koponen J, Anttila M, Pulkkinen K, Heikura T, Toivanen P, Hämäläinen K, Kosma VM, Heinonen S, Alitalo K, Ylä-Herttuala S. Tuppurainen L, et al. Among authors: kokki e. Hum Gene Ther Clin Dev. 2013 Mar;24(1):29-37. doi: 10.1089/humc.2013.006. Epub 2013 Apr 3. Hum Gene Ther Clin Dev. 2013. PMID: 23692381

5

Comparative Study of Adeno-associated Virus, Adenovirus, Bacu lovirus and Lentivirus Vectors for Gene Therapy of the Eyes.

Kalesnykas G, Kokki E, Alasaarela L, Lesch HP, Tuulos T, Kinnunen K, Uusitalo H, Airenne K, Yla-Herttuala S. Kalesnykas G, et al. Among authors: kokki e. Curr Gene Ther. 2017;17(3):235-247. doi: 10.2174/1566523217666171003170348. Curr Gene Ther. 2017. PMID: 28982327

6

Economic burden of fire-related deaths in Finland, 2000-2010: Indirect costs using a human capital approach.

Haikonen K, Lillsunde PM, Lunetta P, Kokki E. Haikonen K, et al. Among authors: kokki e. Burns. 2016 Feb;42(1):56-62. doi: 10.1016/j.burns.2015.10.015. Epub 2015 Dec 12. Burns. 2016. PMID: 26691870

7

Factors associated with the need for information about medicines among pregnant women - a multinational internet-based survey.

Hämeen-Anttila K, Kokki E, Lupattelli A, Nordeng H, Jyrkkä J, Vainio K, Enlund H. Hämeen-Anttila K, et al. Among authors: kokki e. Res Social Adm Pharm. 2015 Mar-Apr;11(2):297-302. doi: 10.1016/j.sapharm.2014.06.003. Epub 2014 Jun 21. Res Social Adm Pharm. 2015. PMID: 25096599

8

Multiple information sources and consequences of conflicting information about medicine use during pregnancy: a multinational Internet-based survey.

Hämeen-Anttila K, Nordeng H, Kokki E, Jyrkkä J, Lupattelli A, Vainio K, Enlund H. Hämeen-Anttila K, et al. Among authors: kokki e. J Med Internet Res. 2014 Feb 20;16(2):e60. doi: 10.2196/jmir.2939. J Med Internet Res. 2014. PMID: 24565696 Free PMC article.

9

Medicines information needs during pregnancy: a multinational comparison.

Hämeen-Anttila K, Jyrkkä J, Enlund H, Nordeng H, Lupattelli A, Kokki E. Hämeen-Anttila K, et al. Among authors: kokki e. BMJ Open. 2013 Apr 26;3(4):e002594. doi: 10.1136/bmjopen-2013-002594. Print 2013. BMJ Open. 2013. PMID: 23624989 Free PMC article.

10

Cancer risk near a polluted river in Finland.

Verkasalo PK, Kokki E, Pukkala E, Vartiainen T, Kiviranta H, Penttinen A, Pekkanen J. Verkasalo PK, et al. Among authors: kokki e. Environ Health Perspect. 2004 Jun;112(9):1026-31. doi: 10.1289/ehp.6741. Environ Health Perspect. 2004. PMID: 15198923 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

11 results

Search Page